Back to search
FDAFDA · Food and drugs·Recall number D-0572-2023

NUX Male Enhancement capsule, 1-count blister card, distributed by SX Power CO., Chicago, Il 60612, UPC 6 01577 51236 3.

Published May 10, 2023 · Recall initiated: April 26, 2023

Summary

FDA records drug Class I recall D-0572-2023, published May 10, 2023 and initiated April 26, 2023. Recalling firm: Gadget Island, Inc; Status: Ongoing; Reported quantity: 18 blister cards; Lot: Lot#: RO 927996, Exp: 12/25/2024. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Gadget Island, Inc
Distributor
Nationwide in the USA.
Lot
Lot#: RO 927996, Exp: 12/25/2024
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was NUX Male Enhancement capsule, 1-count blister card, distributed by SX Power CO., Chicago, Il 60612, UPC 6 01577 51236 3. recalled?

Yes. FDA published recall D-0572-2023 on May 10, 2023. Reported hazard: Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

What should I do if I have this product?

Voluntary: Firm initiated · Letter